Product Code: ETC13263734 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Healthcare-Associated Infection Market was valued at USD 17.5 Billion in 2024 and is expected to reach USD 26.1 Billion by 2031, growing at a compound annual growth rate of 5.20% during the forecast period (2025-2031).
The Global Healthcare-Associated Infection (HAI) market is experiencing steady growth driven by increasing awareness about infection control, rising prevalence of HAIs, and the implementation of stringent regulations by healthcare authorities worldwide. Factors such as the growing number of surgical procedures, rising geriatric population, and the increasing use of invasive medical devices are also contributing to market expansion. Key players in the industry are focusing on developing advanced infection control products and technologies to prevent and manage HAIs effectively. The market is characterized by intense competition, with companies constantly innovating to gain a competitive edge. Geographically, North America dominates the market due to high healthcare expenditure and strict regulatory guidelines, while Asia Pacific is expected to witness significant growth attributed to improving healthcare infrastructure and increasing adoption of infection control measures.
The Global Healthcare-Associated Infection Market is witnessing a growing demand for innovative solutions to reduce the prevalence of hospital-acquired infections, driven by increasing awareness about patient safety and stringent regulations. Key trends include the adoption of advanced disinfection technologies, such as UV-C light and hydrogen peroxide vapor systems, to eliminate pathogens in healthcare facilities. Additionally, the rise of antimicrobial coatings for medical devices and surfaces is gaining traction to prevent the spread of infections. Opportunities lie in the development of rapid diagnostic tools for early detection of infections, as well as the integration of artificial intelligence and big data analytics to predict and prevent healthcare-associated infections. Collaboration between healthcare providers and technology companies will be crucial in addressing these challenges and driving market growth.
The Global Healthcare-Associated Infection Market faces several challenges, including increasing antibiotic resistance, lack of effective infection control measures, inadequate surveillance systems, and limited awareness among healthcare professionals and patients. Antibiotic resistance is a significant concern as it limits treatment options for infections, leading to higher mortality rates and healthcare costs. Inadequate infection control measures in healthcare facilities contribute to the spread of infections, while the lack of robust surveillance systems hinders the timely identification and containment of outbreaks. Additionally, the lack of awareness among healthcare workers and patients about the importance of preventing healthcare-associated infections further exacerbates the problem. Addressing these challenges requires a multi-faceted approach involving improved infection control practices, antibiotic stewardship programs, and enhanced education and training initiatives.
The Global Healthcare-Associated Infection Market is primarily driven by the increasing prevalence of HAIs, growing awareness about infection control measures, and stringent regulations mandating healthcare facilities to implement infection prevention protocols. The rise in surgical procedures, aging population susceptible to infections, and the emergence of antibiotic-resistant bacteria are also significant drivers of market growth. Additionally, advancements in healthcare infrastructure and technologies, along with the increasing emphasis on patient safety and quality of care, are fueling the demand for innovative infection control products and services. Market players are focusing on developing new and improved solutions to address the evolving challenges posed by healthcare-associated infections, further propelling market expansion.
Government policies related to the Global Healthcare-Associated Infection Market mainly focus on improving infection control practices, increasing surveillance and reporting of healthcare-associated infections, and promoting antimicrobial stewardship to combat antibiotic resistance. Many countries have implemented regulations requiring healthcare facilities to adhere to strict protocols for preventing infections, such as proper hand hygiene and environmental cleaning. Additionally, governments are investing in research and development to discover new technologies and treatments for healthcare-associated infections. Some countries also provide financial incentives or penalties to healthcare providers based on their infection rates, aiming to incentivize better infection prevention practices. Overall, government policies aim to reduce the burden of healthcare-associated infections on healthcare systems and improve patient outcomes.
The Global Healthcare-Associated Infection Market is expected to witness steady growth in the coming years due to the increasing awareness about the importance of infection prevention and control measures in healthcare settings. Factors such as the rising prevalence of HAIs, the growing geriatric population, and the implementation of stringent regulations by healthcare authorities are driving market growth. Additionally, the development of advanced technologies for infection control, such as UV disinfection systems and antimicrobial coatings, is expected to further propel market expansion. The market is also likely to benefit from the increasing adoption of preventive strategies by healthcare facilities and the emphasis on improving patient safety. However, challenges such as the high cost of infection control products and the emergence of antibiotic-resistant bacteria may pose obstacles to market growth in the future.
In the Global Healthcare-Associated Infection Market, Asia is anticipated to experience significant growth due to the increasing investments in healthcare infrastructure and rising awareness about infection control measures. North America is expected to dominate the market, driven by advanced healthcare facilities and stringent regulations. Europe is also a key market with a focus on reducing healthcare-associated infections through strict protocols and technological advancements. In the Middle East and Africa region, the market is projected to grow steadily as governments prioritize healthcare improvements. Latin America is witnessing growth with the rising number of healthcare facilities and increasing focus on patient safety. Overall, the global healthcare-associated infection market is expected to see substantial growth across all regions as healthcare systems aim to reduce the prevalence of infections.
Global Healthcare-Associated Infection (HAI) Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Healthcare-Associated Infection (HAI) Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Healthcare-Associated Infection (HAI) Market Revenues & Volume, 2021 & 2031F |
3.3 Global Healthcare-Associated Infection (HAI) Market - Industry Life Cycle |
3.4 Global Healthcare-Associated Infection (HAI) Market - Porter's Five Forces |
3.5 Global Healthcare-Associated Infection (HAI) Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Healthcare-Associated Infection (HAI) Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Global Healthcare-Associated Infection (HAI) Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
3.8 Global Healthcare-Associated Infection (HAI) Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.9 Global Healthcare-Associated Infection (HAI) Market Revenues & Volume Share, By Infections, 2021 & 2031F |
3.10 Global Healthcare-Associated Infection (HAI) Market Revenues & Volume Share, By Diagnostic Tests, 2021 & 2031F |
3.11 Global Healthcare-Associated Infection (HAI) Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Global Healthcare-Associated Infection (HAI) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Healthcare-Associated Infection (HAI) Market Trends |
6 Global Healthcare-Associated Infection (HAI) Market, 2021 - 2031 |
6.1 Global Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Product, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Consumables, 2021 - 2031 |
6.1.3 Global Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Analyzers/Instruments, 2021 - 2031 |
6.2 Global Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Pathogen, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Viral, 2021 - 2031 |
6.2.3 Global Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Bacterial, 2021 - 2031 |
6.2.4 Global Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Fungal, 2021 - 2031 |
6.3 Global Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Treatment, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Sterilization, 2021 - 2031 |
6.3.3 Global Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Chemical, 2021 - 2031 |
6.3.4 Global Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Radiation, 2021 - 2031 |
6.4 Global Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Infections, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Urinary Tract Infections, 2021 - 2031 |
6.4.3 Global Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Surgical Site Infections, 2021 - 2031 |
6.4.4 Global Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Hospital-acquired Pneumonia, 2021 - 2031 |
6.4.5 Global Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By BloodStream Infections, 2021 - 2031 |
6.4.6 Global Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Gastrointestinal Infections, 2021 - 2031 |
6.4.7 Global Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Respiratory Infections, 2021 - 2031 |
6.4.8 Global Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 Global Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Diagnostic Tests, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Traditional Diagnostics, 2021 - 2031 |
6.5.3 Global Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Molecular Diagnostics, 2021 - 2031 |
6.6 Global Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By End Use, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 Global Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.6.3 Global Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.6.4 Global Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By ASCs, 2021 - 2031 |
6.6.5 Global Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Healthcare-Associated Infection (HAI) Market, Overview & Analysis |
7.1 North America Healthcare-Associated Infection (HAI) Market Revenues & Volume, 2021 - 2031 |
7.2 North America Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Healthcare-Associated Infection (HAI) Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Healthcare-Associated Infection (HAI) Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Healthcare-Associated Infection (HAI) Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Product, 2021 - 2031 |
7.4 North America Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Pathogen, 2021 - 2031 |
7.5 North America Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.6 North America Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Infections, 2021 - 2031 |
7.7 North America Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Diagnostic Tests, 2021 - 2031 |
7.8 North America Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By End Use, 2021 - 2031 |
8 Latin America (LATAM) Healthcare-Associated Infection (HAI) Market, Overview & Analysis |
8.1 Latin America (LATAM) Healthcare-Associated Infection (HAI) Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Healthcare-Associated Infection (HAI) Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Healthcare-Associated Infection (HAI) Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Healthcare-Associated Infection (HAI) Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Healthcare-Associated Infection (HAI) Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Product, 2021 - 2031 |
8.4 Latin America (LATAM) Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Pathogen, 2021 - 2031 |
8.5 Latin America (LATAM) Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Treatment, 2021 - 2031 |
8.6 Latin America (LATAM) Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Infections, 2021 - 2031 |
8.7 Latin America (LATAM) Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Diagnostic Tests, 2021 - 2031 |
8.8 Latin America (LATAM) Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By End Use, 2021 - 2031 |
9 Asia Healthcare-Associated Infection (HAI) Market, Overview & Analysis |
9.1 Asia Healthcare-Associated Infection (HAI) Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Healthcare-Associated Infection (HAI) Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Healthcare-Associated Infection (HAI) Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Healthcare-Associated Infection (HAI) Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Healthcare-Associated Infection (HAI) Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Product, 2021 - 2031 |
9.4 Asia Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Pathogen, 2021 - 2031 |
9.5 Asia Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Treatment, 2021 - 2031 |
9.6 Asia Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Infections, 2021 - 2031 |
9.7 Asia Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Diagnostic Tests, 2021 - 2031 |
9.8 Asia Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By End Use, 2021 - 2031 |
10 Africa Healthcare-Associated Infection (HAI) Market, Overview & Analysis |
10.1 Africa Healthcare-Associated Infection (HAI) Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Healthcare-Associated Infection (HAI) Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Healthcare-Associated Infection (HAI) Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Healthcare-Associated Infection (HAI) Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Healthcare-Associated Infection (HAI) Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Product, 2021 - 2031 |
10.4 Africa Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Pathogen, 2021 - 2031 |
10.5 Africa Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Treatment, 2021 - 2031 |
10.6 Africa Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Infections, 2021 - 2031 |
10.7 Africa Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Diagnostic Tests, 2021 - 2031 |
10.8 Africa Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By End Use, 2021 - 2031 |
11 Europe Healthcare-Associated Infection (HAI) Market, Overview & Analysis |
11.1 Europe Healthcare-Associated Infection (HAI) Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Healthcare-Associated Infection (HAI) Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Healthcare-Associated Infection (HAI) Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Healthcare-Associated Infection (HAI) Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Healthcare-Associated Infection (HAI) Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Product, 2021 - 2031 |
11.4 Europe Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Pathogen, 2021 - 2031 |
11.5 Europe Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Treatment, 2021 - 2031 |
11.6 Europe Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Infections, 2021 - 2031 |
11.7 Europe Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Diagnostic Tests, 2021 - 2031 |
11.8 Europe Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By End Use, 2021 - 2031 |
12 Middle East Healthcare-Associated Infection (HAI) Market, Overview & Analysis |
12.1 Middle East Healthcare-Associated Infection (HAI) Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Healthcare-Associated Infection (HAI) Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Healthcare-Associated Infection (HAI) Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Healthcare-Associated Infection (HAI) Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Product, 2021 - 2031 |
12.4 Middle East Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Pathogen, 2021 - 2031 |
12.5 Middle East Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Treatment, 2021 - 2031 |
12.6 Middle East Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Infections, 2021 - 2031 |
12.7 Middle East Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By Diagnostic Tests, 2021 - 2031 |
12.8 Middle East Healthcare-Associated Infection (HAI) Market, Revenues & Volume, By End Use, 2021 - 2031 |
13 Global Healthcare-Associated Infection (HAI) Market Key Performance Indicators |
14 Global Healthcare-Associated Infection (HAI) Market - Export/Import By Countries Assessment |
15 Global Healthcare-Associated Infection (HAI) Market - Opportunity Assessment |
15.1 Global Healthcare-Associated Infection (HAI) Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Healthcare-Associated Infection (HAI) Market Opportunity Assessment, By Product, 2021 & 2031F |
15.3 Global Healthcare-Associated Infection (HAI) Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
15.4 Global Healthcare-Associated Infection (HAI) Market Opportunity Assessment, By Treatment, 2021 & 2031F |
15.5 Global Healthcare-Associated Infection (HAI) Market Opportunity Assessment, By Infections, 2021 & 2031F |
15.6 Global Healthcare-Associated Infection (HAI) Market Opportunity Assessment, By Diagnostic Tests, 2021 & 2031F |
15.7 Global Healthcare-Associated Infection (HAI) Market Opportunity Assessment, By End Use, 2021 & 2031F |
16 Global Healthcare-Associated Infection (HAI) Market - Competitive Landscape |
16.1 Global Healthcare-Associated Infection (HAI) Market Revenue Share, By Companies, 2024 |
16.2 Global Healthcare-Associated Infection (HAI) Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |